Lower riskMedical device recall · FDA · Published November 6, 2024
BD BBL Sensi Disc Ampicillin 2 mcg In-Vitro Test Kits May Give False Resistant Results
Becton Dickinson recalls BD BBL Sensi Disc Ampicillin 2 mcg (AM-2) test kits that may give false resistant results due to decreased potency. Affected lots expire by December 2024 to August 2025. Consumers should check their lot numbers.
BD identified through potency testing as part of a stability test request to monitor Ampicillin AM-2 due to decrease in potency results of 65% at 18 months, may result in falsely resistant result for ampicillin susceptibility
Becton Dickinson is recalling certain BD BBL Sensi Disc Ampicillin 2 mcg (AM-2) test kits that may give false results for bacterial susceptibility testing. This could lead to incorrect treatment decisions if used in medical testing. Read more at govinfonow.com/recall/53556-bd-bbl-sensi-disc-ampicillin-2-mcg-in-vitro-test.
“BD BBL Sensi Disc Ampicillin 2 mcg In-Vitro Test Kits May Give False Resistant Results.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/53556-bd-bbl-sensi-disc-ampicillin-2-mcg-in-vitro-test. Based on FDA recall #Z-0621-2025 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0621-2025%22&limit=1).
The FDA announced on November 6, 2024, that Becton Dickinson & Co. is recalling BD BBL Sensi Disc Ampicillin 2 ¿g (AM-2) due to decreased potency. This issue may result in falsely resistant results for ampicillin susceptibility testing. The recall affects 13,190 units distributed worldwide.
How to tell if you have it
Brand: Becton Dickinson
Product: BD BBL Sensi Disc Ampicillin 2 ¿g (AM-2)
Catalog Number: 231263
UPC: 30382902312636
Lot Numbers and Expiration Dates: 2339360 (12/31/2024), 3010977 (01/31/25), 3058508 (03/31/2025), 3184064 (07/02/2025), 3234190 (08/21/2025)
Distribution: US Nationwide in CA, GA, IL, KY, MA, MD, NE, PA; Canada, Belgium, Singapore, Malaysia
The hazard
Becton Dickinson identified through potency testing that the product's potency decreased to 65% at 18 months. This decrease may result in falsely resistant results for ampicillin susceptibility.
Context
GovInfoNow's records show Becton Dickinson & Co. has 43 other recalls on record since June 1, 2017. Recent recalls include the BD GasP: CO2 Pouch System Recall dated April 7, 2026, and the BD Kiestra Isolate Suspension Cuvette Array recall dated October 23, 2025. Other recent recalls of similar products include the Biomerieux VITEK 2 AST-N461 Test Kit Recall (July 24, 2026), the Biomerieux VITEK 2 AST-N447 Kit Recall (June 4, 2026), and the Biomerieux VITEK 2 Gram-negative Susceptibility Cards recall (January 5, 2026).
How to tell if you have this one
Check the lot number on the kit packaging. Affected lots include 2339360 (expiring 12/31/2024), 3010977 (01/31/2025), 3058508 (03/31/2025), 3184064 (07/02/2025), and 3234190 (08/21/2025).
Brand
Becton Dickinson
Product
BD BBL Sensi Disc Ampicillin 2 ¿g (AM-2) - In-Vitro BD BBL Sensi Disc Ampicillin 2 ¿g (AM-2) are used for
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Lot Number
Look for the lot number on the kit packaging to determine if it is affected.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 8 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “Worldwide - US Nationwide distribution in the states of CA, GA, IL, KY, MA, MD, NE, PA and the countries of Canada, Belgium, Singapore, Malaysia.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: California, Georgia, Illinois, Kentucky, Maryland, Massachusetts, Nebraska, Pennsylvania.
Recall timeline
FDA published this recall 35 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0621-2025 (November 6, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0621-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.